Lead Analysis
Lead compound optimization is the core pivotal stage bridging early drug target screening and formal preclinical research. Poor physicochemical instability, unfavorable in vivo absorption and metabolism performance, or hidden genetic and cardiac toxic risks of lead compounds will trigger high R&D attrition, wasted laboratory costs and delayed overall drug research progress. As a reliable professional testing brand under STEMart, PharmaAnalytica integrates a full set of high-end integrated analytical equipment platforms to support one-stop full-index lead compound characterization. Our self-built dedicated supporting instruments cover HPLC-UV detection systems, UV-potentiometric titration analyzers, high-sensitivity LC-MS/MS quantitative mass spectrometers, high-resolution Q-TOF qualitative mass spectrometers, cell culture intelligent incubation systems, multi-functional microplate readers and standardized electrophysiological detection workstations. We comprehensively output accurate, repeatable and regulatory-aligned compound data, fully assisting pharmaceutical enterprises in rapid compound screening, structural optimization, candidate compound confirmation, and efficiently lowering the overall failure risk of subsequent preclinical and clinical trials.
Specialized Lead Analysis Services
Physicochemical Properties Analysis
We provide full-standard physicochemical property profiling tailored for early lead compound screening and structural optimization, covering core indicators closely related to druggability and formulation feasibility. Relying on high-precision HPLC-UV analytical systems, we conduct equilibrium solubility determination under multiple pH gradient environments to accurately evaluate compound dissolution characteristics and solid-state formulation adaptability. Supported by professional UV-potentiometric titration instruments, we precisely detect lipophilicity LogP/LogD and pKa values, intuitively predicting molecular membrane permeability and in vivo distribution tendency. All data strictly follows pharmaceutical analytical guidelines, supporting researchers to rapidly eliminate compounds with poor solubility and unreasonable lipid distribution, and providing critical basic parameter support for subsequent pharmacokinetic experimental design and preliminary dosage form feasibility assessment in one go.
Pharmacokinetics Analysis
Our comprehensive in vitro and in silico pharmacokinetic (PK) evaluation system efficiently predicts the in vivo absorption, distribution, metabolism and excretion rules of lead compounds in advance, avoiding later-stage PK disqualification losses. We carry out parallel artificial membrane permeability assay to quickly screen high-throughput intestinal absorption potential of batch compounds. Meanwhile, standardized Caco-2 cell monolayer permeability models are constructed to simulate real human intestinal epithelial absorption barriers and verify oral bioavailability levels. Equipped with high-stability LC-MS/MS platforms, we complete quantitative analysis of compound blood concentration, tissue distribution and excretion profiles. Coupled with high-resolution Q-TOF mass spectrometry, we efficiently identify in vitro metabolic fragments, clearance pathways and potential active toxic metabolites, optimizing lead compound metabolic stability in a targeted manner.
Safety Evaluation
We conduct rapid early safety risk warning and preliminary toxicity screening for lead compounds, effectively blocking high-toxicity molecules entering expensive preclinical in vivo trials. Using fully automatic cell culture and multi-mode microplate reader equipment, we perform standardized in vitro cytotoxicity assays to evaluate compound proliferation inhibition effects on normal human cell lines and screen acute cytotoxic risks. We carry out Ames bacterial reverse mutation tests with dedicated microbial incubation systems to detect potential gene mutagenicity hazards. Supported by high-precision cell imaging platforms, we implement in vitro micronucleus tests to assess chromosome damage risks. In addition, we complete in vitro hERG channel electrophysiological assays to evaluate cardiotoxicity and QT prolongation risks. The whole set of safety data fully meets early R&D risk control requirements and greatly improves the safety reliability of optimized lead compounds.
Why Choose PharmaAnalytica?
Interdisciplinary Professional R&D Team
We have a senior interdisciplinary team composed of pharmaceutical analytical chemists, ADME specialists and in vitro toxicologists. The team is proficient in compound structural optimization logic and global pharmaceutical analytical guidelines, capable of solving complex technical problems such as low-purity compound detection and trace metabolite identification to ensure reliable experimental design.
Self-Built Full-Coverage Integrated Instrument Platform
All core detection devices are independently deployed and operated in-house, covering chromatography, spectrometry, cell biology and electrophysiological full-link equipment. No third-party outsourcing links exist, ensuring stable data quality, short experimental cycles and full-process data security controllability for all lead compound analysis projects.
One-Stop Full-Process Comprehensive Service Coverage
We seamlessly integrate physicochemical testing, ADME pharmacokinetic profiling and early safety toxicology evaluation into a closed-loop workflow. It fully meets the whole-cycle analysis demands from early batch lead compound primary screening to later optimized candidate compound confirmation, greatly simplifying enterprise R&D coordination procedures.
High-Precision Data & Customized Flexible Solutions
All testing methods undergo strict methodological verification, with complete original spectral data and audit trails retained permanently. We issue compliant English technical reports for direct project archiving and review. Meanwhile, we provide customized rapid screening schemes according to client compound batches and R&D timelines to accelerate overall project progress.
In summary, backed by STEMart's strong technical strength and standardized laboratory management, PharmaAnalytica relies on complete professional equipment, mature technical systems and experienced experts to deliver efficient, accurate and cost-effective lead compound analysis services. We fully escort global pharmaceutical enterprises in optimizing lead compound structures, locking high-quality candidate drugs, and steadily advancing innovative drug R&D pipelines.
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Need More Information or Request A Quotation?
Related Links
